• Home
  • > News
  • > iQBS Funding Announcements for 2011

June 03, 2011 : Lebanon, NH

iQBS Funding Announcements for 2011

Dartmouth's Institute for Quantitative Biomedical Science (iQBS) has awarded several Director's Grants, as noted below. Applications for these funding opportunities are accepted on a rolling basis throughout the year. See the iQBS funding opportunities page for more details, at http://iqbs.org/research/funding-opportunities/

A Director's DISCOVERY Grant has been awarded to Dr. Mathieu Lupien and the Quantitative Epigenomics Laboratory for the purchase of a GPU high-performance computer that will be used for processing high-dimensional genomics data.

A Director's DISCOVERY Grant has been awarded to Dr. Robert Gross and the Computational Molecular Biology Laboratory for the purchase of a parallel computer node that will be used for processing genomics data.

A Director's Travel Grant has been awarded to Dr. Mathieu Lupien and a fellow graduate student from the Quantitative Epigenomics Laboratory to attend the 2011 AMIA Summit on Translational Bioinformatics in San Francisco. Dr. Lupien will present his work on the genomics of cancer and will represent the iQBS at the meeting.

A Director's Software Grant has been awarded to Dr. Scott Gerber and the Quantitative Proteomics Laboratory for use of the Ingenuity Pathway Analysis (IPA) software package. Dr. Gerber and his colleagues will use IPA to carry out pathway analysis of large-scale proteomics results.

A Director's Software Grant has been awarded to Dr. Craig Tomlinson and the Environmental Diseases Genomics Laboratory for use of the Ariadne Pathway Studio software package. Dr. Tomlinson and his colleagues will use Pathway Studio to carry out pathway analysis of large-scale genomics results.

A Director's Software Grant has been awarded to Dr. Ruth Craig from the Department of Pharmacology and Toxicology for use of the Ariadne Pathway Studio software package. Dr. Craig and her colleagues will use Pathway Studio to carry out pathway analysis of large-scale genomics results for leukemia.